|
|
Volumn 113, Issue 1 SUPPL. 1, 2002, Pages 1-4
|
|
Scientific and clinical challenges in the management of urinary tract infections
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPICILLIN;
ANTIBIOTIC AGENT;
BETA LACTAMASE INHIBITOR;
CEFALOTIN;
CIPROFLOXACIN;
COTRIMOXAZOLE;
ENOXACIN;
FOSFOMYCIN;
GATIFLOXACIN;
LEVOFLOXACIN;
LOMEFLOXACIN;
MOXIFLOXACIN;
NITROFURANTOIN;
OFLOXACIN;
PENICILLIN DERIVATIVE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SPARFLOXACIN;
SULFONAMIDE;
TETRACYCLINE;
TROVAFLOXACIN;
CATHETER;
CATHETERIZATION;
CLINICAL TRIAL;
CONTRACEPTION;
COST EFFECTIVENESS ANALYSIS;
CYSTITIS;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG SAFETY;
ENTEROBACTER;
ESCHERICHIA COLI;
FETUS MORTALITY;
HEALTH CARE UTILIZATION;
HOSPITAL INFECTION;
HOSPITALIZATION;
HUMAN;
KIDNEY FAILURE;
KLEBSIELLA;
MORBIDITY;
PREGNANCY;
PREMATURE LABOR;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
PROTEUS;
PSEUDOMONAS;
PYELONEPHRITIS;
REVIEW;
RISK FACTOR;
SEPTICEMIA;
SERRATIA;
SEXUAL INTERCOURSE;
SIDE EFFECT;
STAPHYLOCOCCUS SAPROPHYTICUS;
UNITED STATES;
URINARY TRACT INFECTION;
|
|
EID: 0037043306
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/s0002-9343(02)01053-7 Document Type: Review |
|
Times cited : (90)
|
|
References (34)
|
